|
|
|
Volumn 24, Issue 5 SUPPL. 17, 1997, Pages
|
|
A phase II trial of epirubicin plus paclitaxel in metastatic breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
GLUCOSE;
PACLITAXEL;
SODIUM CHLORIDE;
ADULT;
ALOPECIA;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
FEMALE;
HEALTH ECONOMICS;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MULTICENTER STUDY;
NEUROPATHY;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTOPENIA;
UNITED KINGDOM;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DISEASE-FREE SURVIVAL;
EPIRUBICIN;
HUMANS;
NEOPLASM METASTASIS;
PACLITAXEL;
PILOT PROJECTS;
QUALITY OF LIFE;
|
|
EID: 0030698643
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (16)
|
